EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC-ND 4.0

Efficacy and safety of risperidone for attention deficit hyperactivity disorder and disruptive behaviour disorders: a systematic review and meta-analysis

S Penubarthi, K Rajamanickam, H A Thappa, R Ayyalasomayajula, P S Chakravarthy, S Vats, A Suklabaidya, S Sarkar

East Asian Archives of Psychiatry · 31.03.2026 · 36 (1) · 40

DOI: 10.12809/eaap25137 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift East Asian Archives of Psychiatry, online erschienen am 31.03.2026. Verfasst von S Penubarthi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Kamineni Institute of Medical Sciences, Narketpally, Nalgonda District, Telangana, India. Hauptthemen laut MEDLINE: Risperidone, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Antipsychotic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RisperidoneAttention Deficit Disorder with HyperactivityAttention Deficit and Disruptive Behavior DisordersAntipsychotic AgentsHumansChildRandomized Controlled Trials as TopicProlactinAggression

Stichwörter der Autor:innen

AggressionAttention deficit disorder with hyperactivityConduct disorderOppositional defiant disorderRisperidone

Substanzen

RisperidoneAntipsychotic AgentsProlactin

Autor:innen und Institutionen

  • Department of Psychiatry, Kamineni Institute of Medical Sciences, Narketpally, Nalgonda District, Telangana, India.
  • Department of Psychiatry, Shanmuga Hospital, Salem, Tamil Nadu, India.
  • Drug De-addiction and Treatment Centre, Department of Psychiatry, PGIMER, Chandigarh, India.
  • Department of Psychiatry, Surabhi Institute of Medical Sciences, Metpally, Siddipet, Telangana, India.
  • Yogitha Neuropsychiatric Centre, Nellore, Andhra Pradesh, India.
  • Department of Psychiatry, Mahatma Gandhi Memorial Medical College, Indore, India.

Zitieren

APA

Penubarthi, S., Rajamanickam, K., Thappa, H. A., Ayyalasomayajula, R., Chakravarthy, P. S., Vats, S., Suklabaidya, A., & Sarkar, S. (2026). Efficacy and safety of risperidone for attention deficit hyperactivity disorder and disruptive behaviour disorders: a systematic review and meta-analysis. East Asian Archives of Psychiatry, 36(1), 40. https://doi.org/10.12809/eaap25137

Vancouver

Penubarthi S, Rajamanickam K, Thappa HA, Ayyalasomayajula R, Chakravarthy PS, Vats S, et al. Efficacy and safety of risperidone for attention deficit hyperactivity disorder and disruptive behaviour disorders: a systematic review and meta-analysis. East Asian Archives of Psychiatry. 2026;36(1):40. doi:10.12809/eaap25137

BibTeX
@article{Penubarthi2026,
  author = {Penubarthi, S and Rajamanickam, K and Thappa, H A and Ayyalasomayajula, R and Chakravarthy, P S and Vats, S and Suklabaidya, A and Sarkar, S},
  title = {Efficacy and safety of risperidone for attention deficit hyperactivity disorder and disruptive behaviour disorders: a systematic review and meta-analysis},
  journal = {East Asian Archives of Psychiatry},
  year = {2026},
  volume = {36},
  number = {1},
  pages = {40},
  doi = {10.12809/eaap25137}
}
Kostenlos starten →